From Bioblast
CZ Ceske Budejovice Zikova A
| O2k-Network Lab | |
|---|---|
| Address | , |
| City | |
| State/Prov | |
| Country | |
| Weblink | |
| Contact | |
| Team | |
| Team previous | |
| Status | |
| Oroboros Events | |
| Topics |
O2k-Publications
| Published | Reference | |
|---|---|---|
| Arbon 2022 Antimicrob Agents Chemother | 2022 | Arbon D, Ženíšková K, Šubrtová K, Mach J, Štursa J, Machado M, Zahedifard F, Leštinová T, Hierro-Yap C, Neuzil J, Volf P, Ganter M, Zoltner M, Zíková A, Werner L, Sutak R (2022) Repurposing of MitoTam: Novel anti-cancer drug candidate exhibits potent activity against major protozoan and fungal pathogens. https://doi.org/10.1128/aac.00727-22 |
| Hierro-Yap 2021 J Biol Chem | 2021 | Hierro-Yap C, Šubrtová K, Gahura O, Panicucci B, Dewar C, Chinopoulos C, Schnaufer A, Zíková A (2021) Bioenergetic consequences of FoF1-ATP synthase/ATPase deficiency in two life cycle stages of Trypanosoma brucei. J Biol Chem 296:100357. |
| Dolezelova 2020 PLoS Biol | 2020 | Doleželová E, Kunzová M, Dejung M, Levin M, Panicucci B, Regnault C, Janzen CJ, Barrett MP, Butter F, Zíková A (2020) Cell-based and multi-omics profiling reveals dynamic metabolic repurposing of mitochondria to drive developmental progression of Trypanosoma brucei. PLoS Biol 18:e3000741. |
O2k-Abstracts
update please
